Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Bucciarelli

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Antioxidants & Redox Signaling|December 17, 2005
Diabetic vascular disease: it's all the RAGEBarry I Hudson, Thoralf Wendt, Loredana G Bucciarelli, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|May 25, 2004
RAGE axis: Animal models and novel insights into the vascular complications of diabetesYoshifumi Naka, Loredana G Bucciarelli, Thoralf Wendt, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Expression of homeobox-containing genes in primary and metastatic colorectal cancerG De Vita, P Barba, N Odartchenko, et al.
Diabetes|April 19, 2008
RAGE and modulation of ischemic injury in the diabetic myocardiumLoredana G Bucciarelli, Radha Ananthakrishnan, Yuying C Hwang, et al.
Cellular and Molecular Life Sciences : CMLS|September 12, 2002
RAGE is a multiligand receptor of the immunoglobulin superfamily: implications for homeostasis and chronic diseaseL G Bucciarelli, T Wendt, L Rong, et al.
The American Journal of Pathology|August 4, 2001
Blockade of receptor for advanced glycation end-products restores effective wound healing in diabetic miceM T Goova, J Li, T Kislinger, et al.
Diabetes & Vascular Disease Research|April 7, 2010
Inflammatory stress in primary venous and aortic endothelial cells of type 1 diabetic miceLoredana G Bucciarelli, Andreas Pollreisz, Moritz Kebschull, et al.
Diabetes & Vascular Disease Research|November 25, 2005
RAGE and its ligands: a lasting memory in diabetic complications?Shi-Fang Yan, Ravichandran Ramasamy, Loredana G Bucciarelli, et al.
Circulation|November 27, 2002
RAGE blockade stabilizes established atherosclerosis in diabetic apolipoprotein E-null miceLoredana G Bucciarelli, Thoralf Wendt, Wu Qu, et al.
Archives of Biochemistry and Biophysics|October 22, 2003
Blockade of receptor for advanced glycation endproducts: a new target for therapeutic intervention in diabetic complications and inflammatory disordersBarry I Hudson, Loredana G Bucciarelli, Thoralf Wendt, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Antioxidants & Redox Signaling|December 17, 2005
Diabetic vascular disease: it's all the RAGEBarry I Hudson, Thoralf Wendt, Loredana G Bucciarelli, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|May 25, 2004
RAGE axis: Animal models and novel insights into the vascular complications of diabetesYoshifumi Naka, Loredana G Bucciarelli, Thoralf Wendt, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Expression of homeobox-containing genes in primary and metastatic colorectal cancerG De Vita, P Barba, N Odartchenko, et al.
Diabetes|April 19, 2008
RAGE and modulation of ischemic injury in the diabetic myocardiumLoredana G Bucciarelli, Radha Ananthakrishnan, Yuying C Hwang, et al.
Cellular and Molecular Life Sciences : CMLS|September 12, 2002
RAGE is a multiligand receptor of the immunoglobulin superfamily: implications for homeostasis and chronic diseaseL G Bucciarelli, T Wendt, L Rong, et al.
The American Journal of Pathology|August 4, 2001
Blockade of receptor for advanced glycation end-products restores effective wound healing in diabetic miceM T Goova, J Li, T Kislinger, et al.
Diabetes & Vascular Disease Research|April 7, 2010
Inflammatory stress in primary venous and aortic endothelial cells of type 1 diabetic miceLoredana G Bucciarelli, Andreas Pollreisz, Moritz Kebschull, et al.
Diabetes & Vascular Disease Research|November 25, 2005
RAGE and its ligands: a lasting memory in diabetic complications?Shi-Fang Yan, Ravichandran Ramasamy, Loredana G Bucciarelli, et al.
Circulation|November 27, 2002
RAGE blockade stabilizes established atherosclerosis in diabetic apolipoprotein E-null miceLoredana G Bucciarelli, Thoralf Wendt, Wu Qu, et al.
Archives of Biochemistry and Biophysics|October 22, 2003
Blockade of receptor for advanced glycation endproducts: a new target for therapeutic intervention in diabetic complications and inflammatory disordersBarry I Hudson, Loredana G Bucciarelli, Thoralf Wendt, et al.
Pageof 3